Physician

Rheumatology

Samuel H. Zwillich practices Rheumatology. He received awards:"Fellow (FACP)" and "Fellow". Samuel Zwillich is a published doctor as well. He has 35 publications published. The latest was: The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumato...

Publications

---

• Tofacitinib with methotrexate in third-line treatment of patients with active rheumatoid arthritis: Patient-reported outcomes from a Phase 3 trial.
• Tofacitinib versus methotrexate in rheumatoid arthritis.
• Safety and Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, for the Treatment of Rheumatoid Arthritis in Open-label, Longterm Extension Studies.
• Measuring the effect of therapy in rheumatoid arthritis clinical trials from the patient's perspective.
• Reply to letter to the editor: "Serious adverse event reporting - missing in action"
• A Phase 2B dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rhe...
• Phase 2B dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis wi...
• Evaluating the efficacy of sequential biologic therapies for rheumatoid arthritis patients with an inadequate response to tumor necrosis factor-α inhibitors.
• Double-blind, placebo-controlled, dose-escalation study to evaluate the pharmacologic effect of CP-690,550 in patients with psoriasis.
• The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage ...
• Where is the evidence that the resurgence of nomograms is harmful?
• Effects of tofacitinib monotherapy on patient-reported outcomes in a randomized phase 3 study of patients with active rheumatoid arthritis and inadequate responses to ...
• T cell receptor analysis in rheumatoid arthritis: what have we learnt?
• Enterococcus: an unusual cause of septic arthritis.
• Male hypogonadism and scleroderma.
• Universal spondylodiscitis in a patient with erosive peripheral arthritis and apatite crystal deposition.
• Olsalazine in Reiter''s syndrome.
• Fast food arthritis--a clinico-pathologic study of post-Salmonella reactive arthritis.
• T-lymphocyte clones responsive to Shigella flexneri.
• Molecular mimicry in the pathogenesis of rheumatic diseases.
• Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: res...
• Valdecoxib is more efficacious than rofecoxib in relieving pain associated with oral surgery.
• Olsalazine in ankylosing spondylitis: a pilot study.
• Multifocal Staphylococcus aureus infection originating from the sacroiliac joint in a patient with rheumatoid arthritis.
• Outcome versus activity in rheumatoid arthritis: a focus blurred.
• Treatment of the seronegative spondyloarthropathies with sulfasalazine.
• The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumato...
• CCR1 antagonists for the treatment of autoimmune diseases.
• Phase II study of tofacitinib (CP-690,550) combined with methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate.
• CCR1 antagonists: what have we learned from clinical trials.
• Co-administration of the JAK inhibitor CP-690,550 and methotrexate is well tolerated in patients with rheumatoid arthritis without need for dose adjustment.
• Therapeutic targeting of Janus kinases.
• Cartilage preservation by inhibition of Janus kinase 3 in two rodent models of rheumatoid arthritis.
• Celecoxib is efficacious and well tolerated in treating signs and symptoms of ankylosing spondylitis.

Schools

---

• Albany Medical College

Doctors Specialties

---

• Rheumatology

Accepted Insurances

---

Awards

---

• Fellow (FACP)
• Fellow

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Alan L. Brodsky, MD This Doctor is OpenDoctor Recommended.
	Dr. Zoran Kurepa, MD This Doctor is OpenDoctor Recommended.
	Dr. Wassila Amari, MD This Doctor is OpenDoctor Recommended.
	Dr. Thomas D. Geppert, MD This Doctor is OpenDoctor Recommended.
	Dr. David Rosenstock, MD This Doctor is OpenDoctor Recommended.
	Dr. Riteesha G. Reddy, MD This Doctor is OpenDoctor Recommended.
	Dr. David R. Karp, MD
	Dr. Susan S. Comer, MD
	Dr. Elizabeth B. Solow, MD This Doctor is OpenDoctor Recommended.
	Dr. Joel D. Taurog, MD This Doctor is OpenDoctor Recommended.
	Dr. Marcia S. Genta, MD This Doctor is OpenDoctor Recommended.
	Dr. Marissa N. Martinez, MD
	Julia A. Dilliard

---

Doctor Directory | TOS | twitter | FB | Angel | blog